Skip to Content

LDT (Tyzeka 600 mg)

Generic Name: telbivudine

Pill with imprint LDT is White, Elliptical / Oval and has been identified as Tyzeka 600 mg. It is supplied by Novartis Corporation.

Tyzeka is used in the treatment of hepatitis b and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Tyzeka 600 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LDT

Tyzeka

Generic Name
telbivudine
Imprint
LDT
Strength
600 mg
Color
White
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Novartis Corporation
National Drug Code (NDC)
00078-0538

Get help with Imprint Code FAQs.

Related Images for "LDT"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.